FindTrial
Sign In

EPO

DRUG10 trials

Sponsors

ARCAGY/ GINECO GROUP, University Hospital, Angers, Sun Yat-sen University, University of Washington, University of Texas Southwestern Medical Center

Conditions

AnaemiaAnemiaCardiovascular DiseaseChronic Kidney DiseaseExtreme PrematurityFallopian Tube CancerMultiple SclerosisMyocardial Infarction

Phase 1

Active Preoperative Anemia Management in Patients Undergoing Cardiac Surgery
TerminatedNCT02189889
University of Texas Southwestern Medical CenterAnemia, Cardiovascular Disease
Start: 2013-04-09End: 2019-07-26Updated: 2020-10-23

Phase 2

Use of FACT-GOG/NTX Questionnaire in Peripheral Neurotoxicity & Validation of a French Version of This Questionnaire
CompletedNCT00517621
ARCAGY/ GINECO GROUPFallopian Tube Cancer, Ovarian Cancer, Peritoneal Neoplasms
Start: 2006-02-28End: 2010-10-31Target: 100Updated: 2011-02-25
EPOMI Study: ErythroPOietin in Myocardial Infarction
CompletedNCT00648089
University Hospital, AngersMyocardial Infarction
Start: 2008-04-30End: 2010-12-31Updated: 2011-01-31
Erythropoietin in Premature Infants to Prevent Encephalopathy
TerminatedNCT02550054
Children's Hospital of Fudan UniversityPremature Infant
Start: 2015-09-08End: 2016-12-30Updated: 2023-12-29
Erythropoietin Protects Very Preterm Infants Against Necrotizing Enterocolitis
CompletedNCT03919500
Zhengzhou UniversityPremature Infant
Start: 2014-01-31End: 2019-04-30Updated: 2019-04-19

Phase 3

Preterm Erythropoietin Neuroprotection Trial (PENUT Trial)
CompletedNCT01378273
University of WashingtonExtreme Prematurity
Start: 2013-12-31End: 2020-02-28Updated: 2020-08-26
Probiotics Against Erythropoietin Resistance in Chronic Kidney Disease Patients.
Not yet recruitingNCT07296146
Badr UniversityAnaemia, Chronic Kidney Disease, Regular Hemodialysis
Start: 2025-12-15End: 2026-05-15Target: 80Updated: 2025-12-22

Phase 4

Use of Epoetin Alfa and Iron Derisomaltose in Treatment of Anemia in Patients With Sepsis or Septic Shock: a Randomized Controlled Trial
RecruitingNCT06670963
Piotr CzempikAnemia, Sepsis, Septic Shock
Start: 2024-11-10End: 2027-04-01Target: 200Updated: 2024-12-27

Unknown Phase

Characteristic Study on Chinese Patients With Multiple Sclerosis
NCT00818103
Sun Yat-sen UniversityMultiple Sclerosis
Start: 2006-01-31End: 2016-01-31Target: 600Updated: 2009-09-29
The Effect of Micro-doses Erytropoietin on Exercise Capacity in Male and Females
NCT04965961
University of CopenhagenSports Drug Abuse
Start: 2019-08-28End: 2024-01-31Updated: 2023-11-29

Related Papers

Time to regain birthweight and in-hospital outcomes among United States-born extremely preterm newborns.
2025-11-101 citations
Acute Kidney Injury and Neurodevelopmental Outcomes in Extremely Premature Neonates: A Secondary Analysis of a Randomized Clinical Trial.
2025-11-03
Contemporary definitions of infant growth failure and neurodevelopmental and behavioral outcomes in extremely premature infants at two years of age.
2024-01-099 citations
Time to regain birthweight and association with neurodevelopmental outcomes among extremely preterm newborns.
2024-01-095 citations
Association Between Urinary Biomarkers and CKD in Extremely Low Gestational Age Neonates.
2023-11-041 citations
Acute Kidney Injury Defined by Fluid-Corrected Creatinine in Premature Neonates
JAMA Network Open2023-08-1020 citations
Association of High-Dose Erythropoietin With Circulating Biomarkers and Neurodevelopmental Outcomes Among Neonates With Hypoxic Ischemic Encephalopathy
JAMA Network Open2023-07-0730 citations
Association of Fluid Balance With Short- and Long-term Respiratory Outcomes in Extremely Premature Neonates
JAMA Network Open2022-12-2937 citations
Iron supplementation and the risk of bronchopulmonary dysplasia in extremely low gestational age newborns.
2022-06-205 citations
Postnatal maximal weight loss, fluid administration, and outcomes in extremely preterm newborns.
2022-03-2521 citations
Enteral Iron Supplementation in Infants Born Extremely Preterm and its Positive Correlation with Neurodevelopment; Post Hoc Analysis of the Preterm Erythropoietin Neuroprotection Trial Randomized Controlled Trial.
2021-07-2712 citations
Erythropoietin Improves Poor Outcomes in Preterm Infants with Intraventricular Hemorrhage.
2021-05-0617 citations
Effect of early prophylactic low-dose recombinant human erythropoietin on retinopathy of prematurity in very preterm infants.
2020-10-1915 citations
Effect of High-Dose Erythropoietin on Blood Transfusions in Extremely Low Gestational Age Neonates
JAMA Pediatrics2020-08-1746 citations
Erythropoietin prevents necrotizing enterocolitis in very preterm infants: a randomized controlled trial.
2020-08-0827 citations
A Randomized Trial of Erythropoietin for Neuroprotection in Preterm Infants
New England Journal of Medicine2020-01-15304 citations
Impact of processing methods on urinary biomarkers analysis in neonates.
2017-08-197 citations